Crystal engineering of pharmaceutical cocrystals in the discovery and development of improved drugs
The subject of crystal engineering started in the 1970s with the study of topochemical
reactions in the solid state. A broad chemical definition of crystal engineering was published …
reactions in the solid state. A broad chemical definition of crystal engineering was published …
Pharmaceutical cocrystals, salts and multicomponent systems; intermolecular interactions and property based design
As small molecule drugs become harder to develop and less cost effective for patient use,
efficient strategies for their property improvement become increasingly important to global …
efficient strategies for their property improvement become increasingly important to global …
Pharmaceutical cocrystals: along the path to improved medicines
NK Duggirala, ML Perry, Ö Almarsson… - Chemical …, 2016 - pubs.rsc.org
Cocrystals, a long known but understudied class of crystalline solids, have attracted interest
from crystal engineers and pharmaceutical scientists in the past decade and are now an …
from crystal engineers and pharmaceutical scientists in the past decade and are now an …
Pharmaceutical cocrystals and poorly soluble drugs
R Thakuria, A Delori, W Jones, MP Lipert, L Roy… - International journal of …, 2013 - Elsevier
In recent years cocrystal formation has emerged as a viable strategy towards improving the
solubility and bioavailability of poorly soluble drugs. In this review the success of numerous …
solubility and bioavailability of poorly soluble drugs. In this review the success of numerous …
Cocrystal engineering of pharmaceutical solids: Therapeutic potential and challenges
Cocrystals are an emerging class of crystalline materials composed of two or more different
molecules in the same crystal lattice that are physically connected by non-ionic and non …
molecules in the same crystal lattice that are physically connected by non-ionic and non …
Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium
I Sathisaran, SV Dalvi - Pharmaceutics, 2018 - mdpi.com
Biopharmaceutics Classification System (BCS) Class II and IV drugs suffer from poor
aqueous solubility and hence low bioavailability. Most of these drugs are hydrophobic and …
aqueous solubility and hence low bioavailability. Most of these drugs are hydrophobic and …
Coupling complementary strategy to flexible graph neural network for quick discovery of coformer in diverse co-crystal materials
Y Jiang, Z Yang, J Guo, H Li, Y Liu, Y Guo, M Li… - Nature …, 2021 - nature.com
Cocrystal engineering have been widely applied in pharmaceutical, chemistry and material
fields. However, how to effectively choose coformer has been a challenging task on …
fields. However, how to effectively choose coformer has been a challenging task on …
Mechanochemistry: A green approach in the preparation of pharmaceutical cocrystals
M Solares-Briones, G Coyote-Dotor, JC Páez-Franco… - Pharmaceutics, 2021 - mdpi.com
Mechanochemistry is considered an alternative attractive greener approach to prepare
diverse molecular compounds and has become an important synthetic tool in different fields …
diverse molecular compounds and has become an important synthetic tool in different fields …
[PDF][PDF] Pharmaceutical Cocrystals: An Overview.
Poor aqueous solubility and low oral bioavailability of an active pharmaceutical ingredient
are the major constraints during the development of new product. Various approaches have …
are the major constraints during the development of new product. Various approaches have …
[HTML][HTML] Pharmaceutical cocrystals: regulatory and strategic aspects, design and development
DD Gadade, SS Pekamwar - Advanced pharmaceutical bulletin, 2016 - ncbi.nlm.nih.gov
Cocrystal is a concept of the supramolecular chemistry which is gaining the extensive
interest of researchers from pharmaceutical and chemical sciences and of drug regulatory …
interest of researchers from pharmaceutical and chemical sciences and of drug regulatory …